CALX insider sells 24,000 shares after $8.03 option exercise
Rhea-AI Filing Summary
Calix, Inc. reported an insider transaction by Chief Product Officer Shane Eleniak. On 11/10/2025, he exercised 24,000 stock options at an exercise price of $8.03 and sold 24,000 shares of common stock at a weighted average price of $64.135. The sale occurred through multiple trades in a price range of $64.00 to $64.295, with full trade details available upon request.
Following these transactions, his direct beneficial ownership of common stock was 0 shares. The filing notes the option grant was fully vested and exercisable as of February 14, 2023, with an expiration date of February 14, 2029.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: option exercise and same-day sale, neutral impact.
The Chief Product Officer executed a standard exercise-and-sell: 24,000 options at $8.03 exercised, and 24,000 shares sold at a weighted average of $64.135 on 11/10/2025. The transaction reports a multi-trade range of $64.00–$64.295, which is typical disclosure.
Post-transaction direct common stock ownership is reported as 0 shares. The option was fully vested as of February 14, 2023, with expiration on February 14, 2029. This filing records insider activity but does not, by itself, signal operational or financial changes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 24,000 | $0.00 | -- |
| Exercise | Common Stock | 24,000 | $8.03 | $193K |
| Sale | Common Stock | 24,000 | $64.135 | $1.54M |
Footnotes (1)
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.295, inclusive. Full information on the number of shares sold at each sale price is available upon request. 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023.